Inventor · disambiguated record
Michio Ichimura
Also filed as: ICHIMURA MICHIO
22 granted patents·7 pending applications·750 citations·filing 1988–2014
96Inventor score
Files withKYOWA HAKKO KOGYO KK17MILLENNIUM PHARM INC5KYOWA HAKKO KIRIN CO LTD2MOCHIDA PHARM CO LTD2MILLENNIUMIUM PHARMACEUTICALS1
Top patents by PatentIndex Score
29 records- 0197US4923990APyrindamycins A and B and duocarmycin A antibiotics derived from certain streptomyces cultureKYOWA HAKKO KOGYO KK·Filed 1988·Granted May 8, 1990·169 cites·2 claims
- 0294US6423716B1Nitrogenous heterocyclic compoundsKYOWA HAKKO KOGYO KK·Filed 1999·Granted Jul 23, 2002·138 cites·24 claims
- 0392US5138059ADc-89 compounds and process for their preparationKYOWA HAKKO KOGYO KK·Filed 1989·Granted Aug 11, 1992·44 cites·1 claims
- 0491US6716987B1Derivatives of benzofuran or benzodioxazole compoundsKYOWA HAKKO KOGYO KK·Filed 2001·Granted Apr 6, 2004·38 cites·7 claims
- 0591US6472391B2Nitrogen-containing heterocyclic compoundsMILLENNIUM PHARM INC·Filed 2000·Granted Oct 29, 2002·44 cites·9 claims
- 0691US6207667B11,3 diazines with platelet-derived growth factor receptor inhibitory activityKYOWA HAKKO KOGYO KK·Filed 2000·Granted Mar 27, 2001·47 cites·9 claims
- 0787US6169088B11,3 diazines with platelet-derived growth factor receptor inhibitory activityKYOWA HAKKO KOGYO KK·Filed 1998·Granted Jan 2, 2001·65 cites·9 claims
- 0885US6514996B2Derivatives of benzofuran or benzodioxoleKYOWA HAKKO KOGYO KK·Filed 1997·Granted Feb 4, 2003·41 cites·8 claims
- 0983US6982266B2Quinazoline derivatives as kinase inhibitorsKYOWA HAKKO KOGYO KK·Filed 2001·Granted Jan 3, 2006·12 cites·11 claims
- 1083US6750218B2Nitrogen-containing heterocyclic compoundsMILLENNIUMIUM PHARMACEUTICALS·Filed 2002·Granted Jun 15, 2004·22 cites·9 claims
- 1177US5698560AImidazoquinazoline derivativesKYOWA HAKKO KOGYO KK·Filed 1996·Granted Dec 16, 1997·23 cites·5 claims
- 1277US5661147AImidazoquinazoline derivativesKYOWA HAKKO KOGYO KK·Filed 1994·Granted Aug 26, 1997·20 cites·8 claims
- 1375US7560461B2Quinazoline derivatives as kinase inhibitorsMILLENNIUM PHARM INC·Filed 2005·Granted Jul 14, 2009·1 cites·5 claims
- 1474US8324205B2Quinazoline derivatives as kinase inhibitorsPANDEY ANJALI·Filed 2009·Granted Dec 4, 2012·1 cites·4 claims
- 1568US6956039B2Nitrogenous heterocylic compoundsKYOWA HAKKO KOGYO KK·Filed 2001·Granted Oct 18, 2005·3 cites·10 claims
- 1666US6222035B1[1,2,4] triazolo [1,5-C] pyrimidine derivativesKYOWA HAKKO KOGYO KK·Filed 1999·Granted Apr 24, 2001·25 cites·36 claims
- 1764US7329655B2Nitrogenous heterocyclic compoundsMILLENNIUM PHARM INC·Filed 2001·Granted Feb 12, 2008·2 cites·8 claims
- 1863US8022071B2Nitrogenous heterocyclic compoundsMILLENNIUM PHARM INC·Filed 2007·Granted Sep 20, 2011·0 cites·16 claims
- 1963US6127541AImidazoquinazoline derivativesKYOWA HAKKO KOGYO KK·Filed 1997·Granted Oct 3, 2000·10 cites·13 claims
- 2063US2015133439A1Quinazoline derivatives as kinase inhibitorsMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 2162US5202421AAnticoagulant substance obtained from urine and process for the preparation thereofMOCHIDA PHARM CO LTD·Filed 1989·Granted Apr 13, 1993·20 cites·5 claims
- 2261US5300490AAnticoagulant substance obtained from urineMOCHIDA PHARM CO LTD·Filed 1992·Granted Apr 5, 1994·21 cites·3 claims
- 2359US2013274252A1Quinazoline derivatives as kinase inhibitorsKYOWA HAKKO KOGYO KK·Filed 2012·Application pending·0 cites
- 2450US2006063770A1Nitrogenous heterocyclic compoundsKYOWA HAKKO KOGYO KK·Filed 2005·Application pending·0 cites
- 2545US2011020931A1Proliferation promoting agent for neural stem cellsKYOWA HAKKO KIRIN CO LTD·Filed 2009·Application pending·0 cites
- 2644US2006058366A1Jnk inhibitorKYOWA HAKKO KOGYO KK·Filed 2003·Application pending·0 cites
- 2743US2010016250A1Toll-like receptor 9 agonistsKYOWA HAKKO KIRIN CO LTD·Filed 2007·Application pending·0 cites
- 2839US6306847B1Condensed purine derivativesKYOWA HAKKO KOGYO KK·Filed 1998·Granted Oct 23, 2001·4 cites·7 claims
- 2938US2004259881A1Nitrogenous heterocyclic compoundsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →